Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme

Triplett, Todd A, Garrison, Kendra C, Marshall, Nicholas, Donkor, Moses, Blazeck, John, Lamb, Candice, Qerqez, Ahlam, Dekker, Joseph D, Tanno, Yuri, Lu, Wei-Cheng, Karamitros, Christos S, Ford, Kyle, Tan, Bing, Zhang, Xiaoyan M, McGovern, Karen, Coma, Silvia, Kumada, Yoichi, Yamany, Mena S, Sentandreu, Enrique, Fromm, George, Tiziani, Stefano, Schreiber, Taylor H, Manfredi, Mark, Ehrlich, Lauren I R, Stone, Everett, Georgiou, George·2018·Nature Biotechnology

DOI 10.1038/nbt.4180

Cited by (326)

Items 101–200 of 326

Metabolic reprogramming: a bridge between aging and tumorigenesis
Drapela, Stanislav, Ilter, Didem, Gomes, Ana P. · 2022 · Molecular Oncology
Manipulating T-cell metabolism to enhance immunotherapy in solid tumor
Chen Chen, Zehua Wang, Yi Ding, Yanru Qin · 2022 · Frontiers in Immunology
Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials
Hemaasri-Neya Girithar, Ananda Staats Pires, Seong Beom Ahn, Gilles J. Guillemin, Laurence Gluch, Benjamin Heng · 2023 · British Journal of Cancer
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, Yingjie Wang, Pan Sun, Zhaohe Jing, Zhengrui Li, Yudi Xu, Bo Ram Han, Jian Liu · 2024 · Cancer Letters
Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment
Racheal Louise Johnson, Michele Cummings, Amudha Thangavelu, Georgios Theophilou, Diederick De Jong, Nicolas Michel Orsi · 2021 · Cancers
Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism
Quanjun Yang, Juan Hao, Mengyi Chi, Yaxian Wang, Bo Xin, Jinglu Huang, Jin Lu, Jie Li, Xipeng Sun, Chunyan Li et al. · 2022 · OncoImmunology
Metabolic advantages of regulatory T cells dictated by cancer cells
Masaki Kondo, Shogo Kumagai, Hiroyoshi Nishikawa · 2023 · International Immunology
Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy
Zhiren Wang, Wenpan Li, Yanhao Jiang, Tuyen Ba Tran, Leyla Estrella Cordova, Jinha Chung, Minhyeok Kim, Georg T. Wondrak, Jennifer Erdrich, Jianqin Lu · 2023 · Nature Communications
Charge convertible biomimetic micellar nanoparticles for enhanced melanoma-targeted therapy through tumor cells and tumor-associated macrophages dual chemotherapy with IDO immunotherapy
Kaipei Luo, Yunfei Lian, Min Zhang, Hua Yu, Guangji Wang, Juan Li · 2021 · Chemical Engineering Journal
Targeting allosteric regulation of cancer metabolism
Daniel M. Kremer, Costas Andreas Lyssiotis · 2022 · Nature Chemical Biology
Enzyme Mimicking Based on the Natural Melanin Particles from Human Hair
Sheng Hong, Qiuling Zhang, Diwei Zheng, Cheng Zhang, Yu Zhang, Jing‐Jie Ye, Han Lei Cheng, Xian‐Zheng Zhang · 2019 · iScience
The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer
Ricardo A. Léon-Letelier, Rongzhang Dou, Jody V. Vykoukal, Ali Hussein Abdel Sater, Edwin Justin Ostrin, Samir Hanash, Johannes Francois Fahrmann · 2023 · Frontiers in Oncology
The Aryl Hydrocarbon Receptor: Impact on the Tumor Immune Microenvironment and Modulation as a Potential Therapy
Brian D. Griffith, Timothy L. Frankel · 2024 · Cancers
Microbial modulation of tryptophan metabolism links gut microbiota to disease and its treatment
Pengfei Zhao, Yuqi Chen, Shuyu Zhou, Fei Li · 2025 · Pharmacological Research
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality
Jeremy P. Gygi, Cole P. Maguire, Ravi K. Patel, Pramod S. Shinde, Anna Konstorum, Casey P. Shannon, Leqi Xu, Annmarie Hoch, Naresh Doni Jayavelu, Impacc Network et al. · 2024 · Journal of Clinical Investigation
Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
Xuan Han, Yu Zhu, Juan Ke, Yufeng Zhai, Min Huang, Xin Zhang, Hongjie He, Xiao‐Jing Zhang, Xuehong Zhao, Kaikai Guo et al. · 2024 · Cell Death Discovery
Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβ
Takumi Kudo, Mirja Tamara Prentzell, Soumya R. Mohapatra, Felix Sahm, Zhongliang Zhao, Ingrid Grummt, Wolfgang Wick, Christiane A. Opitz, Michael Platten, Edward W. Green · 2020 · Frontiers in Immunology
Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies
Huijie Han, Hélder A. Santos · 2024 · Advanced Materials
Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung Cancer
Johannes Francois Fahrmann, Jody V. Vykoukal, Edwin Justin Ostrin · 2020 · Frontiers in Oncology
The immunotherapeutic role of indoleamine 2,3‐dioxygenase in head and neck squamous cell carcinoma: A systematic review
Daniel J. Lin, James Chean Khun Ng, Lei Huang, Max Robinson, James O’Hara, Janet Ann Wilson, Andrew L. Mellor · 2021 · Clinical Otolaryngology
CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors
Jiahao Liu, Xiaofei Jiao, Ding Ma, Yong Fang, Qinglei Gao · 2024 · Med
Targeting tumor metabolism to augment CD8+ T cell anti-tumor immunity
Huan Liu, Wenyong Yang, Jingwen Jiang · 2024 · Journal of Pharmaceutical Analysis
IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment
Zhaorong Wu, Hongye Wang, Zhigang Zheng, Yan Lin, Linke Bian, Haigang Geng, Xiaorong Huang, Jiufei Zhu, Hongshu Jing, Yi Zhang et al. · 2025 · Journal of Translational Medicine
Reversing Immunosuppression in Hypoxic and Immune‐Cold Tumors with Ultrathin Oxygen Self‐Supplementing Polymer Nanosheets under Near Infrared Light Irradiation
Wei Jiang, Lei Wang, Qin Wang, Han Zhou, Yinchu Ma, Wang Xu Dong, Hangxun Xu, Yucai Wang · 2021 · Advanced Functional Materials
Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance
Javier Traba, Michael N. Sack, Thomas A. Waldmann, Olga M. Antón · 2021 · Frontiers in Immunology
Semiconducting Polymer Nanoparticles as Activatable Nanomedicines for Combinational Phototherapy
Mengke Xu, Chi Zhang, Ziling Zeng, Kanyi Pu · 2021 · ACS Applied Polymer Materials
Self‐Splittable Transcytosis Nanoraspberry for NIR‐II Photo‐Immunometabolic Cancer Therapy in Deep Tumor Tissue
Li Wang, Wei Jiang, Yanhong Su, Meixiao Zhan, Shaojun Peng, Hang Liu, Ligong Lu · 2022 · Advanced Science
Activating Nanomedicines with Electromagnetic Energy for Deep‐Tissue Induction of Immunogenic Cell Death in Cancer Immunotherapy
Fengshuo Wang, Kanyi Pu, Jingchao Li · 2022 · Small Methods
The relationship between tryptophan metabolism and gut microbiota: Interaction mechanism and potential effects in infection treatment
Tongchao Pei, Wenweiran Li, Ziyang Zhou, Qinyu Zhang, Guohong Yu, Sokun Yin, Hui Chen, Jianguo Tang · 2025 · Microbiological Research
Urinary detection of early responses to checkpoint blockade and of resistance to it via protease-cleaved antibody-conjugated sensors
Quoc D. Mac, Anirudh Sivakumar, Hathaichanok Phuengkham, Congmin Xu, James R. Bowen, Fang‐Yi Su, Samuel Z. Stentz, Hyoungjun Sim, Adrian M. Harris, Tonia T. Li et al. · 2022 · Nature Biomedical Engineering
Metabolic guidance and stress in tumors modulate antigen-presenting cells
Jaeoh Park, Limei Wang, Ping‐Chih Ho · 2022 · Oncogenesis
Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated
Arian Charehjoo, Jamal Majidpoor, Keywan Mortezaee · 2023 · International Immunopharmacology
Targeting amino acid-metabolizing enzymes for cancer immunotherapy
Yvonne Grobben · 2024 · Frontiers in Immunology
Macrophage-coated tumor cluster aggravates hepatoma invasion and immunotherapy resistance via generating local immune deprivation
Junya Ning, Yingnan Ye, Hongru Shen, Runjiao Zhang, Huikai Li, Tianqiang Song, Rui Zhang, Pengpeng Liu, Guidong Chen, Hailong Wang et al. · 2024 · Cell Reports Medicine
Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities
Yawen Liu, Xiangyun Zong, Patricia Altea‐Manzano, Jie Fu · 2025 · Protein & Cell
Indoleamine 2,3-Dioxygenase 1 Inhibitor-Loaded Nanosheets Enhance CAR-T Cell Function in Esophageal Squamous Cell Carcinoma
Jingwen Shao, Lin Hou, Jinyan Liu, Yulin Liu, Jie Ning, Qitai Zhao, Yi Zhang · 2021 · Frontiers in Immunology
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols
Oren Barboy, Akhiad Bercovich, Hanjie Li, Yaniv Eyal-Lubling, Adam Yalin, Yuval Shapir Itai, Kathleen Abadie, Mor Zada, Eyal David, Shir Shlomi-Loubaton et al. · 2024 · Nature Cancer
Remodeling metabolic fitness: Strategies for improving the efficacy of chimeric antigen receptor T cell therapy
Luyan Shen, Yefei Xiao, Jiahe Tian, Zheming Lu · 2022 · Cancer Letters
Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression
Mengna Wang, Yuhong Liu, Yanshi Li, Tao Lü, Min Wang, Zhaobo Cheng, Lin Chen, Tongling Wen, Min Pan, Guohua Hu · 2024 · Advanced Science
Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy
Małgorzata Wachowska, Joanna Stachura, Katarzyna Tonecka, Klaudyna Fidyt, Agata Braniewska, Zuzanna Sas, Iwona Kotuła, Tomasz P. Rygiel, Louis Boon, Jakub Gołąb et al. · 2020 · Cancer Immunology Immunotherapy
Electric Pulse Responsive Magnetic Nanoclusters Loaded with Indoleamine 2,3-Dioxygenase Inhibitor for Synergistic Immuno-Ablation Cancer Therapy
Bo Yu, Wentao Zhang, Kijung Kwak, Hyunjun Choi, Dong‐Hyun Kim · 2020 · ACS Applied Materials & Interfaces
Non-invasive skin sampling of tryptophan/kynurenine ratio in vitro towards a skin cancer biomarker
Skaidre Jankovskaja, Johan Engblom, Melinda Rezeli, György Marko‐Varga, Tautgirdas A Ruzgas, Sebastian Björklund · 2021 · Scientific Reports
Discovery and biological evaluation of tanshinone derivatives as potent dual inhibitors of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase
Jiangxin Liu, Jian Xing Ren, Kun Yang, Shuang Chen, Xinni Yang, Qin‐Shi Zhao · 2022 · European Journal of Medicinal Chemistry
Tumor Metabolism as a Regulator of Tumor–Host Interactions in the B-Cell Lymphoma Microenvironment—Fueling Progression and Novel Brakes for Therapy
Anna C. Beielstein, Christian Philipp Pallasch · 2019 · International Journal of Molecular Sciences
Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma
Ali Mehdi, Mikhaël Attias, Niaz Mahmood, Ani Arakelian, Catalin Liviu Dragos Mihalcioiu, Ciriaco A. Piccirillo, Moshe Szyf, Shafaat Ahmed Rabbani · 2020 · Frontiers in Oncology
Gastric Cancer Cell-Derived Kynurenines Hyperactive Regulatory T Cells to Promote Chemoresistance via the IL-10/STAT3/BCL2 Signaling Pathway
Dandan Wu, Zhongli Wang · 2022 · DNA and Cell Biology
Cladosporium protease/doxorubicin decorated Fe3O4@SiO2 nanocomposite: An efficient nanoparticle for drug delivery and combating breast cancer
Leila Vahabi, Parviz Rashidi Ranjbar, Fatemeh Davar · 2022 · Journal of Drug Delivery Science and Technology
IDO1 and inflammatory neovascularization: bringing new blood to tumor-promoting inflammation
Alexander J. Muller, Arpita Mondal, Souvik Dey, George C. Prendergast · 2023 · Frontiers in Oncology
Data-driven engineering of protein therapeutics
Matthew S. Faber, Timothy A. Whitehead · 2019 · Current Opinion in Biotechnology
Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)
Joyce Yongxu Huang, Tricia L. Larose, Hung Nguyen Luu, Renwei Wang, Anouar Fanidi, Karine Alcala, Victoria L. Stevens, Stephanie J. Weinstein, Demetrius Albanes, Neil E. Caporaso et al. · 2019 · International Journal of Cancer
Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
Qiongjie Hu, Yueli Shi, Huang Wang, Bing Li, Zhiyong Xu · 2025 · Experimental Hematology and Oncology
From Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
Masaru Tanaka, László Vécsei · 2025 · Biomedicines
Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis
Ricardo A. Léon-Letelier, Ali Hussein Abdel Sater, Yihui Chen, Soyoung Park, Ranran Wu, Ehsan Irajizad, Jennifer B. Dennison, Hiroyuki Katayama, Jody V. Vykoukal, Samir Hanash et al. · 2023 · Cancers
Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy
Rui M. L. Coelho, Reno Debets, Dora Hammerl · 2025 · Molecular Cancer
Metabolic and Immunological Subtypes of Esophageal Cancer Reveal Potential Therapeutic Opportunities
Ryan J. King, Fang Qiu, Fang Yu, Pankaj K. Singh · 2021 · Frontiers in Cell and Developmental Biology
Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD
Joshua Walker, Sean Richards, Stephen A. Whelan, Sung Bok Yoo, Teresa Lynn Russell, Nkiruka V. Arinze, Saran Lotfollahzadeh, Marc Arthur Napoleon, Mostafa Belghasem, Norman Lee et al. · 2021 · Journal of the American Society of Nephrology
Self‐Delivering Nanodrugs Developed via Small‐Molecule‐Directed Assembly and Macrophage Cloaking for Sonodynamic‐Augmented Immunotherapy
Fang Xie, Zongjunlin Liu, Peiyuan Wang, Meimei Cai, Yang Li, Jianghua Yan, Qin Lin, Fanghong Luo · 2022 · Advanced Healthcare Materials
Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase
Saeko Yoshioka, Tomonori Ikeda, Sogo Fukuchi, Yurika Kawai, Katsumi Ohta, Hisashi Murakami, Naohisa Ogo, Daisuke Muraoka, Osamu Takikawa, Akira Asai · 2022 · International Journal of Tryptophan Research
Development of a microdevice-based human mesenchymal stem cell-mediated drug delivery system
Junfei Xia, Ang‐Chen Tsai, Wenhao Cheng, Xuegang Yuan, Teng Ma, Jingjiao Guan · 2019 · Biomaterials Science
Targeting metabolism to improve CAR-T cells therapeutic efficacy
Shasha Liu, Yuyu Zhao, Yaoxin Gao, Feng Li, Yi Zhang · 2024 · Chinese Medical Journal
Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives
Umme Hani, Vikram T. Choudhary, Mohammed Ghazwani, Yahia Alghazwani, Riyaz Ali M. Osmani, Gururaj S Kulkarni, Hosakote Gurumallappa Shivakumar, Shahid Ud Din Wani, Sathishbabu Paranthaman · 2024 · Pharmaceutics
A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
Qian Huang, Yanna Lei, Xiaoying Li, Fukun Guo, Ming Liu · 2020 · Frontiers in Cell and Developmental Biology
EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer
Carolin Selenz, Anik Compes, Marieke Nill, Sven Borchmann, Margarete Odenthal, Alexandra Florin, Johannes Brägelmann, Reinhard Büttner, Lydia Meder, Roland Tillmann Ullrich · 2022 · Cancers
ALDH1A1 promotes immune escape of tumor cells through ZBTB7B-glycolysis pathway
Mingyuan Wang, Taoli Wang, Jinjin Wang, Yuexin Yang, Xi Li, Huan Chen, Jingnan Liao · 2024 · Cell Death and Disease
Non-invasive monitoring of low molecular weight biomarkers relevant to skin inflammation and cancer
Skaidre Jankovskaja · 2021
Inhibiting CXCR4 reduces immunosuppressive effects of myeloid cells in breast cancer immunotherapy
Nicholas G. Ciavattone, Avinash S. Bevoor, Alex P. Farfel, Aasia O. Rehman, Kenneth K. Y. Ho, Edwin C. Rock, Yu‐Chih Chen, Kathryn E. Luker, Brock A. Humphries, Gary D. Luker · 2025 · Scientific Reports
Caffeine enhances antitumor T-cell activity by suppressing kynurenine pathway in colorectal cancer
Y. Liu, Zhengyu Liu, Yating Hu, Yunyan Ling, Shunjie Qing, Yang Liu, Yizhi Zhan, Zhiyong Shen, Yuan Fang, Haijun Deng · 2025 · Nature Communications
Advanced Strategies of Enzyme Activity Regulation for Biomedical Applications
Zihan Chen, Yu Zhao, Yang Liu · 2022 · ChemBioChem
Amino Acid Metabolism-Regulated Nanomedicine for Enhanced Tumor Immunotherapy through Synergistic Regulation of Immune Microenvironment
Xiuying Duan, Yilei Zhao, Houyang Hu, Xuechun Wang, Jie Yan, Songyan Li, Yueying Zhang, Jianwei Jiao, Guiqiang Zhang · 2024 · Biomaterials Research
Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation
Christoph Steeneck, Olaf D. Kinzel, Simon J. Anderhub, Martin Hornberger, Sheena Pinto, Barbara Morschhaeuser, Floriane C. M. Braun, Gerald Kleymann, Thomas Karl Hoffmann · 2020 · ACS Medicinal Chemistry Letters
Advances in immune therapies for the treatment of microsatellite instability‑high/deficient mismatch repair metastatic colorectal cancer (Review)
Khalil Choucair, Maluki Radford, Ajay Kr Bansal, Robin Park, Anwaar Saeed · 2021 · International Journal of Oncology
Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Túlio Teruo Yoshinaga, M.L. Dagli, Cristina de Oliveira Massoco, José Roberto Kfoury · 2023 · Molecular Biology Reports
Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells
Sandeep Kumar, Sunil Kumar Singh, Navin Viswakarma, Gautam V. Sondarva, Rakesh Sathish Nair, Periannan Sethupathi, Matthew J. Dorman, Subhash C. Sinha, Kent F. Hoskins, Gregory R. J. Thatcher et al. · 2020 · Journal for ImmunoTherapy of Cancer
Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzyme
John Blazeck, Christos S. Karamitros, Kyle M. Ford, Catrina M. Somody, Ahlam N. Qerqez, Kyle Murray, Nathaniel T. Burkholder, Nicholas Marshall, Anirudh Sivakumar, Weicheng Lu et al. · 2022 · Nature Catalysis
Effect of metabolism on the immune microenvironment of breast cancer
Yingming Zhou, Hu Wang, Yi Luo, Biguang Tuo, Xuemei Liu, Taolang Li · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
Julien Champagne, Morten Milek Nielsen, Xiaodong Feng, Jasmine Montenegro Navarro, Abhijeet Pataskar, Rhianne Voogd, Lisanne Giebel, Remco Nagel, Nadine Berenst, Amos Fumagalli et al. · 2025 · Immunity
Liquid metal-based nanocomposite with triple-amplified Fenton-like reaction for tumor chemodynamic/photothermal/immunotherapy
Shuai Wang, Yang Zou, Li Zhang, Yonggang Lv · 2025 · Chemical Engineering Journal
IDO family: the metabolic crossroads connecting immunity, nerves and tumors
Xijie Wang, Zhe Chen, Linxi Chen, Chengfeng Qiu · 2026 · Journal of Translational Medicine
Metabolic rewiring directs melanoma immunology
Ningyue Sun, Yangzi Tian, Yuhan Chen, Weinan Guo, Chunying Li · 2022 · Frontiers in Immunology
Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment
Lu Chen, Yuchen Wang, Qingqing Hu, Yuxi Liu, Xuchen Qi, Zhihua Tang, Haihong Hu, Nengming Lin, Su Zeng, Lushan Yu · 2023 · Frontiers in Immunology
Immunometabolism: a new dimension in immunotherapy resistance
Chaoyue Xiao, Wei Xiong, Yiting Xu, Jian Peng Zou, Yue Zeng, Junqi Liu, Yurong Peng, Chunhong Hu, Fang Wu · 2023 · Frontiers of Medicine
Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
Yishi Xu, Yaqing Liu, Yi Ge, Haozhe Li, Yi Zhang, Liping Wang · 2023 · Frontiers in Pharmacology
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen Chen, Peng Han, Yanping Qing · 2024 · Autoimmunity Reviews
The role of metabolic reprogramming in immune escape of triple-negative breast cancer
Ruochen Bao, Hongtao Qu, Baifeng Li, Kai Cheng, Yandong Miao, Jiangtao Wang · 2024 · Frontiers in Immunology
Single enzyme nanoparticle, an effective tool for enzyme replacement therapy
Dong Hyun Kim, Han Sol Lee, Tae-Wan Kwon, Young-Min Han, Nae-Won Kang, Mee Yeon Lee, Dae‐Duk Kim, Myeong Gyu Kim, Jae‐Young Lee · 2020 · Archives of Pharmacal Research
Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer
Anshuman Panda, Shridar Ganesan · 2021 · Frontiers in Genetics
Epacadostat Overcomes Cetuximab Resistance in Colorectal Cancer by Targeting IDO ‐Mediated Tryptophan Metabolism
Yimin Zhou, Qian Tao, Chu‐Bin Luo, Jinsong Chen, Genwen Chen, Jianyong Sun · 2025 · Cancer Science
The Emerging Landscape for Combating Resistance Associated with Energy‐Based Therapies via Nanomedicine
Qitao Hu, Huali Zuo, Jessica C. Hsu, Cheng Zeng, Zhou Tian, Zhouyi Sun, Weibo Cai, Zhe Tang, Weiyu Chen · 2023 · Advanced Materials
Zinc dampens antitumor immunity by promoting Foxp3+ regulatory T cells
Narayan Sugandha, Sugandha Narayan, Rajdeep Dalal, Zaigham Abbas Rizvi · 2024 · Frontiers in Immunology
Profiling Nascent Tumor Extracellular Vesicles via Metabolic Timestamping and Aptamer-Driven Specific Click Chemistry
Qiuyue Wu, Yinyan Zeng, Wencheng Wang, Sinong Liu, Yihao Huang, Yuqian Zhang, Ximing Chen, Zhenlong You, Chi Zhang, Tonghao Wang et al. · 2025 · Journal of the American Chemical Society
Combination of PD-1 Checkpoint Blockade and Botulinum Toxin Type A1 Improves Antitumor Responses in Mouse Tumor Models of Melanoma and Colon Carcinoma
Seongsung Kwak, Ji‐Young Lee, Min Ju Kim, Hyo Jin Lee, Dong‐Kyu Lee, Jiyeon Kang, Won-Ho Kang, Woo‐Chan Son, Deu John M. Cruz · 2023 · Immunological Investigations
Dual-enzyme decorated semiconducting polymer nanoagents for second near-infrared photoactivatable ferroptosis-immunotherapy
Yue Liu, Renjie Lu, Meng Li, Danling Cheng, Fengshuo Wang, Xumei Ouyang, Yitian Zhang, Qin Zhang, Jingchao Li, Shaojun Peng · 2024 · Materials Horizons
Metabolic Modulation of Kynurenine Based on Kynureninase-Loaded Nanoparticle Depot Overcomes Tumor Immune Evasion in Cancer Immunotherapy
Se-Youl Chae, Hojeong Shin, J.I. Woo, Seounghun Kang, Soo Min Lee, Dal‐Hee Min · 2024 · ACS Applied Materials & Interfaces
Interfering tumor metabolism by bimetallic nanoagent for amplifying nanocatalytic-mediated glioblastoma immunotherapy
Qian‐Xiao Huang, Jun‐Long Liang, Mei‐Ting Niu, Xiao‐Kang Jin, Chengyuan Dong, Si‐Xue Cheng, Xian‐Zheng Zhang · 2024 · Nano Today
Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
Manxiu Huai, Yingjie Wang, Junhao Li, Jiaxing Pan, Fang Zhen Sun, Feiyu Zhang, Yi Zhang, Leiming Xu · 2024 · Journal of Nanobiotechnology
Functional nanoplatform for modulating cellular forces to enhance antitumor immunity via mechanotransduction
Wanheng Zhang, Shuqin Liu, Yan Hou, Shihui Xu, Jiayan An, Kyubae Lee, Qi Miao, Nana Wang, Yongtao Wang, Mengze Ma · 2025 · Journal of Controlled Release
LAMP1 targeting of the large T antigen of Merkel cell polyomavirus results in potent CD4 T cell responses and tumor inhibition
Claire Buchta Rosean, Erica C. Leyder, Jeneice Hamilton, Joseph J. Carter, Denise A. Galloway, David M. Koelle, Paul Nghiem, Teri Heiland · 2023 · Frontiers in Immunology
Near-Infrared Photoactivatable Immunomodulatory Nanoparticles for Combinational Immunotherapy of Cancer
Ningyue Yu, Mengbin Ding, Jingchao Li · 2021 · Frontiers in Chemistry
Advances in Antibody-Based Immune-Stimulating Drugs: Driving Innovation in Cancer Therapy
R R Zhao, Xingxing Fan · 2025 · International Journal of Molecular Sciences
Overcoming current challenges to T-cell receptor therapy via metabolic targeting to increase antitumor efficacy, durability, and tolerability
Wendy Mao · 2022 · Frontiers in Immunology